Topics

PFIZER REPORTS FIRST-QUARTER 2019 RESULTS

06:45 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
First-Quarter 2019 Revenues of $13.1 Billion, Reflecting 5% Operational Growth Driven by 7% Operational Growth from Pfizer Biopharmaceuticals Group and 1% Operational Growth From Upjohn First-Quarter ...

Other Sources for this Article

Media
Joan Campion 212.733.2798

Investors
Chuck Triano 212.733.3901
Ryan Crowe 212.733.8160
Bryan Dunn 212.733.8917

NEXT ARTICLE

More From BioPortfolio on "PFIZER REPORTS FIRST-QUARTER 2019 RESULTS"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...